查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411876

內分泌檢測市場：按類型、技術、適應症和最終用戶分類 - 2024-2030 年全球預測

Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Technology (Clinical Chemistry, Immunoassay, Tandem Mass Spectroscopy), Indication, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年內分泌檢測市場規模為27.9億美元，2024年預計達30億美元，2030年將達48.6億美元，複合年成長率為8.24%。

全球內分泌檢測市場

主要市場統計
基準年[2023] 27.9億美元
預測年份 [2024] 30億美元
預測年份 [2030] 48.6億美元
複合年成長率（%） 8.24%
內分泌檢測市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估內分泌檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對內分泌檢測市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-內分泌檢測市場的市場規模與預測是多少？

2-內分泌檢測市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-內分泌檢測市場的技術趨勢和法律規範是什麼？

4-內分泌檢測市場主要廠商的市場佔有率為何？

5-進入內分泌檢測市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 內分泌疾病的盛行率在全世界不斷增加。
      • 提高對早期發現內分泌疾病重要性的認知
      • 更多採用現場護理測試設備
    • 抑制因素
      • 內分泌檢測相關的高成本
    • 機會
      • 擴大分析和測試方法的技術進步
      • 醫療政策和報銷制度不斷完善
    • 任務
      • 依賴傳統的荷爾蒙測定
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章內分泌檢測市場：依類型

  • 皮質醇測試
  • 硫酸磊晶（DHEAS）測試
  • 雌二醇（E2）測試
  • 濾泡刺激素(FSH) 測試
  • 人類絨毛膜促性腺激素分泌(hCG) 荷爾蒙測試
  • 胰島素測試
  • 黃體激素（LH）測試
  • 黃體酮測試
  • 催乳素測試
  • 睪酮測試
  • 甲狀腺刺激素（TSH）測試

第7章內分泌檢測市場：依技術分類

  • 臨床化學
  • 免疫檢測
  • 串聯式質譜法

第8章內分泌檢測市場適應症

  • 愛迪生氏症
  • 庫欣氏症
  • 糖尿病
  • 格雷夫茲病
  • 橋本氏甲狀腺炎

第9章內分泌檢測市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 調查機構

第10章 南北美洲內分泌檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區內分泌檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲內分泌檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • ACON Laboratories, Inc.
    • Agilent Technologies, Inc.
    • BioCheck Inc.
    • Biogenix Inc. Pvt. Ltd
    • bioMerieux SA
    • Blueprint Genetics Oy
    • Creative Diagnostics
    • Danaher Corporation
    • Diagnostic Automation/Cortez Diagnostics Inc.
    • DiaSorin SpA
    • Eagle Biosciences
    • EKF Diagnostics Holdings Plc
    • Eurofins Analytical Laboratories Inc.
    • Getein Biotech, Inc.
    • Laboratory Corporation of America Holdings
    • MP Biomedicals, LLC
    • Ortho-Clinical Diagnostics, Inc.
    • Quest Diagnostics Incorporated
    • Randox Laboratories Ltd.
    • Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-69324464D113

[191 Pages Report] The Endocrine Testing Market size was estimated at USD 2.79 billion in 2023 and expected to reach USD 3.00 billion in 2024, at a CAGR 8.24% to reach USD 4.86 billion by 2030.

Global Endocrine Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.79 billion
Estimated Year [2024] USD 3.00 billion
Forecast Year [2030] USD 4.86 billion
CAGR (%) 8.24%
Endocrine Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Endocrine Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Endocrine Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Endocrine Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., BioCheck Inc., Biogenix Inc. Pvt. Ltd, bioMerieux SA, Blueprint Genetics Oy, Creative Diagnostics, Danaher Corporation, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., Eagle Biosciences, EKF Diagnostics Holdings Plc, Eurofins Analytical Laboratories Inc., Getein Biotech, Inc., Laboratory Corporation of America Holdings, MP Biomedicals, LLC, Ortho-Clinical Diagnostics, Inc., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Endocrine Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Cortisol Test
    • Dehydroepiandrosterone Sulfate (DHEAS) Test
    • Estradiol (E2) Test
    • Follicle Stimulating Hormone (FSH) Test
    • Human Chorionic Gonadotropin (hCG) Hormone Test
    • Insulin Test
    • Luteinizing Hormone (LH) Test
    • Progesterone Test
    • Prolactin Test
    • Testosterone Test
    • Thyroid Stimulating Hormone (TSH) Test
  • Technology
    • Clinical Chemistry
    • Immunoassay
    • Tandem Mass Spectroscopy
  • Indication
    • Addison's Disease
    • Cushing's Disease
    • Diabetes
    • Graves' Disease
    • Hashimoto Thyroiditis
  • End-User
    • Diagnostic Centers
    • Hospitals
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Endocrine Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Endocrine Testing Market?

3. What are the technology trends and regulatory frameworks in the Endocrine Testing Market?

4. What is the market share of the leading vendors in the Endocrine Testing Market?

5. Which modes and strategic moves are suitable for entering the Endocrine Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Endocrine Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of endocrine disorders globally
      • 5.1.1.2. Increased awareness of the importance of early detection of endocrine disorders
      • 5.1.1.3. Growing adoption of point-of-care testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with endocrine tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding technological advancements in assay and testing methods
      • 5.1.3.2. Increasing improvements in healthcare policies and reimbursement systems
    • 5.1.4. Challenges
      • 5.1.4.1. Reliance on conventional hormone assays
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Endocrine Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Cortisol Test
  • 6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
  • 6.4. Estradiol (E2) Test
  • 6.5. Follicle Stimulating Hormone (FSH) Test
  • 6.6. Human Chorionic Gonadotropin (hCG) Hormone Test
  • 6.7. Insulin Test
  • 6.8. Luteinizing Hormone (LH) Test
  • 6.9. Progesterone Test
  • 6.10. Prolactin Test
  • 6.11. Testosterone Test
  • 6.12. Thyroid Stimulating Hormone (TSH) Test

7. Endocrine Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Clinical Chemistry
  • 7.3. Immunoassay
  • 7.4. Tandem Mass Spectroscopy

8. Endocrine Testing Market, by Indication

  • 8.1. Introduction
  • 8.2. Addison's Disease
  • 8.3. Cushing's Disease
  • 8.4. Diabetes
  • 8.5. Graves' Disease
  • 8.6. Hashimoto Thyroiditis

9. Endocrine Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals
  • 9.4. Research Institutes

10. Americas Endocrine Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endocrine Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endocrine Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. ACON Laboratories, Inc.
    • 14.1.3. Agilent Technologies, Inc.
    • 14.1.4. BioCheck Inc.
    • 14.1.5. Biogenix Inc. Pvt. Ltd
    • 14.1.6. bioMerieux SA
    • 14.1.7. Blueprint Genetics Oy
    • 14.1.8. Creative Diagnostics
    • 14.1.9. Danaher Corporation
    • 14.1.10. Diagnostic Automation/Cortez Diagnostics Inc.
    • 14.1.11. DiaSorin S.p.A.
    • 14.1.12. Eagle Biosciences
    • 14.1.13. EKF Diagnostics Holdings Plc
    • 14.1.14. Eurofins Analytical Laboratories Inc.
    • 14.1.15. Getein Biotech, Inc.
    • 14.1.16. Laboratory Corporation of America Holdings
    • 14.1.17. MP Biomedicals, LLC
    • 14.1.18. Ortho-Clinical Diagnostics, Inc.
    • 14.1.19. Quest Diagnostics Incorporated
    • 14.1.20. Randox Laboratories Ltd.
    • 14.1.21. Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • 14.1.22. Siemens Healthcare GmbH
    • 14.1.23. Thermo Fisher Scientific Inc.
    • 14.1.24. Trivitron Healthcare
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ENDOCRINE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENDOCRINE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ENDOCRINE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ENDOCRINE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENDOCRINE TESTING MARKET DYNAMICS
  • FIGURE 7. ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ENDOCRINE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ENDOCRINE TESTING MARKET SIZE, BY FOLLICLE STIMULATING HORMONE (FSH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ENDOCRINE TESTING MARKET SIZE, BY LUTEINIZING HORMONE (LH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ENDOCRINE TESTING MARKET SIZE, BY PROGESTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ENDOCRINE TESTING MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ENDOCRINE TESTING MARKET SIZE, BY TESTOSTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ENDOCRINE TESTING MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ENDOCRINE TESTING MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 200. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 201. ENDOCRINE TESTING MARKET LICENSE & PRICING